Vine, Jacob
Lee, John H.
Kravitz, Max S.
Grossestreuer, Anne V.
Balaji, Lakshman
Leland, Shannon B.
Berlin, Noa
Moskowitz, Ari
Donnino, Michael W.
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (T32HL155020, T32HL155020, T32HL155020, T32HL155020, K24HL127101)
National Institute of General Medical Sciences (K23GM128005)
National Center for Complementary and Integrative Health (R21AT005119)
Article History
Received: 7 November 2023
Accepted: 25 January 2024
First Online: 6 February 2024
Declarations
:
: The two RCTs, the Thiamine in Septic Shock Trial (TSS) (NCT01070810) and the Thiamine for Renal Protection in Septic Shock Trial (TRPSS) (NCT03550794), were approved by local Institutional Review Boards and overseen by Data Safety and Monitoring Boards. All study participants or their legal representatives were asked for written informed consent.
: Not applicable.
: The authors declare no competing interests.